-
Signature
-
/s/ Brian Savage, Attorney-in-fact
-
Stock symbol
-
ABNB
-
Transactions as of
-
Mar 8, 2024
-
Transactions value $
-
-$6,872,250
-
Form type
-
4
-
Date filed
-
3/12/2024, 04:05 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
ABNB |
Class A Common Stock |
Options Exercise |
$2.81M |
+23K |
+15.79% |
$122.41 |
169K |
Mar 8, 2024 |
Direct |
|
transaction |
ABNB |
Class A Common Stock |
Options Exercise |
$1.5M |
+25K |
+14.84% |
$59.91* |
194K |
Mar 8, 2024 |
Direct |
|
transaction |
ABNB |
Class A Common Stock |
Options Exercise |
$1M |
+25K |
+12.92% |
$40.18* |
219K |
Mar 8, 2024 |
Direct |
|
transaction |
ABNB |
Class A Common Stock |
Sale |
-$12.2M |
-73K |
-33.4% |
$167.00 |
146K |
Mar 8, 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
ABNB |
Stock Option |
Options Exercise |
$0 |
-23K |
-25% |
$0.00 |
68.9K |
Mar 8, 2024 |
Class A Common Stock |
23K |
$122.41 |
Direct |
F2 |
transaction |
ABNB |
Stock Option |
Options Exercise |
$0 |
-25K |
-17.41% |
$0.00 |
119K |
Mar 8, 2024 |
Class A Common Stock |
25K |
$59.91 |
Direct |
F3 |
transaction |
ABNB |
Stock Option |
Options Exercise |
$0 |
-25K |
-20.83% |
$0.00 |
95K |
Mar 8, 2024 |
Class A Common Stock |
25K |
$40.18 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: